Emanuelle Bellaguarda

934 total citations
24 papers, 488 citations indexed

About

Emanuelle Bellaguarda is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Emanuelle Bellaguarda has authored 24 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 9 papers in Epidemiology and 8 papers in Surgery. Recurrent topics in Emanuelle Bellaguarda's work include Inflammatory Bowel Disease (11 papers), Microscopic Colitis (9 papers) and Eosinophilic Esophagitis (6 papers). Emanuelle Bellaguarda is often cited by papers focused on Inflammatory Bowel Disease (11 papers), Microscopic Colitis (9 papers) and Eosinophilic Esophagitis (6 papers). Emanuelle Bellaguarda collaborates with scholars based in United States, Denmark and Sweden. Emanuelle Bellaguarda's co-authors include Stephen B. Hanauer, Eugene B. Chang, David T. Rubin, Jean‐Frédéric Colombel, Andrés Yarur, Shailja C. Shah, Berkeley N. Limketkai, Ikuo Hirano, Joel Pekow and Anne Grosen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Gut.

In The Last Decade

Emanuelle Bellaguarda

19 papers receiving 486 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emanuelle Bellaguarda United States 10 198 184 145 106 75 24 488
J.‐F. Rahier Belgium 8 166 0.8× 160 0.9× 114 0.8× 190 1.8× 61 0.8× 14 446
Klaus Theede Denmark 11 363 1.8× 320 1.7× 182 1.3× 61 0.6× 54 0.7× 27 498
Katia El Jurdi United States 11 246 1.2× 190 1.0× 98 0.7× 37 0.3× 50 0.7× 27 389
Jordi Gordillo Spain 16 470 2.4× 404 2.2× 227 1.6× 109 1.0× 40 0.5× 46 701
Colombel Jf France 11 232 1.2× 232 1.3× 147 1.0× 87 0.8× 29 0.4× 33 427
Victoria Rai United States 12 305 1.5× 219 1.2× 105 0.7× 72 0.7× 45 0.6× 38 529
Aurada Cholapranee United States 3 238 1.2× 196 1.1× 76 0.5× 70 0.7× 24 0.3× 6 331
Camilla Solberg Norway 5 456 2.3× 331 1.8× 222 1.5× 166 1.6× 27 0.4× 5 572
Petrease H Patton Canada 4 368 1.9× 280 1.5× 97 0.7× 56 0.5× 24 0.3× 5 489
Steven Jeuring Netherlands 11 584 2.9× 465 2.5× 257 1.8× 61 0.6× 49 0.7× 27 679

Countries citing papers authored by Emanuelle Bellaguarda

Since Specialization
Citations

This map shows the geographic impact of Emanuelle Bellaguarda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emanuelle Bellaguarda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emanuelle Bellaguarda more than expected).

Fields of papers citing papers by Emanuelle Bellaguarda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emanuelle Bellaguarda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emanuelle Bellaguarda. The network helps show where Emanuelle Bellaguarda may publish in the future.

Co-authorship network of co-authors of Emanuelle Bellaguarda

This figure shows the co-authorship network connecting the top 25 collaborators of Emanuelle Bellaguarda. A scholar is included among the top collaborators of Emanuelle Bellaguarda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emanuelle Bellaguarda. Emanuelle Bellaguarda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grosen, Anne, et al.. (2024). Tofacitinib Does Not Impair Sperm Quality in Men With Ulcerative Colitis. Inflammatory Bowel Diseases. 31(3). 882–884.
2.
Gupta, Nancy, Emanuelle Bellaguarda, Q. Eileen Wafford, Joseph D. Feuerstein, & Vitaliy Poylin. (2022). Post-Operative Outcomes in Patients Undergoing Abdominal Surgery for Crohn's Disease Treated with Pre-Operative Ustekinumab. SHILAP Revista de lepidopterología. 11(3). 60–67.
3.
Weaver, Kimberly N., Xian Zhang, Xiangfeng Dai, et al.. (2021). Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID. Inflammatory Bowel Diseases. 28(10). 1497–1505. 63 indexed citations
4.
Bressler, Brian, Andrés Yarur, Mark S. Silverberg, et al.. (2021). Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Results from the EVOLVE Study. Journal of Crohn s and Colitis. 15(10). 1694–1706. 95 indexed citations
5.
Bellaguarda, Emanuelle & Stephen B. Hanauer. (2020). Checkpoint Inhibitor–Induced Colitis. The American Journal of Gastroenterology. 115(2). 202–210. 69 indexed citations
6.
Bellaguarda, Emanuelle, et al.. (2020). Disordered Eating, Body Dissatisfaction, and Psychological Distress in Patients with Inflammatory Bowel Disease (IBD). Journal of Clinical Psychology in Medical Settings. 27(2). 310–317. 28 indexed citations
7.
Gupta, Nancy, Joseph D. Feuerstein, Q. Eileen Wafford, Emanuelle Bellaguarda, & Vitaliy Poylin. (2020). 804 PRE-OPERATIVE USTEKINUMAB TREATMENT AND POST-OPERATIVE COMPLICATIONS IN PATIENTS WITH CROHN'S DISEASE: SYSTEMATIC REVIEW AND META-ANALYSIS. Gastroenterology. 158(6). S–1531.
8.
9.
Limketkai, Berkeley N., Shailja C. Shah, Ikuo Hirano, Emanuelle Bellaguarda, & Jean‐Frédéric Colombel. (2019). Epidemiology and implications of concurrent diagnosis of eosinophilic oesophagitis and IBD based on a prospective population-based analysis. Gut. 68(12). 2152–2160. 48 indexed citations
10.
Gupta, Nancy, et al.. (2019). P041 An Interesting Case of Refractory Immune-Mediated Esophageal Stricture Following Immunotherapy With Nivolumab Treated With Esophageal Dilation. The American Journal of Gastroenterology. 114(1). S11–S11. 2 indexed citations
11.
Christensen, Britt, Dejan Micić, Peter G. Gibson, et al.. (2018). Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease. Alimentary Pharmacology & Therapeutics. 47(6). 753–762. 59 indexed citations
12.
Bellaguarda, Emanuelle, et al.. (2018). Mo1809 - Disordered Eating, Body Dissatisfaction, and Psychological Distress in Patients with Inflammatory Bowel Disease (IBD). Gastroenterology. 154(6). S–809. 1 indexed citations
13.
Grosen, Anne, Jens Kelsen, Christian Lodberg Hvas, Emanuelle Bellaguarda, & Stephen B. Hanauer. (2017). The Influence of Methotrexate Treatment on Male Fertility and Pregnancy Outcome After Paternal Exposure. Inflammatory Bowel Diseases. 23(4). 561–569. 32 indexed citations
14.
Christensen, Britt, Dejan Micić, Peter R. Gibson, et al.. (2017). Vedolizumab is Safe and Effective for IBD, but has no Effect on Liver Biochemistry in Patients with Concurrent PSC. Gastroenterology. 152(5). S405–S405. 1 indexed citations
15.
Liu, Kevin, et al.. (2016). Primary Adenocarcinoma of an Ileostomy in Crohn's Disease. ACG Case Reports Journal. 3(1). e112–e112. 2 indexed citations
16.
Liu, Kevin, Emanuelle Bellaguarda, Dyanna L. Gregory, et al.. (2016). Attenuation of Endoscopic Inflammatory and Stenotic Features in Patients with Co-existing Eosinophilic Esophagitis and Inflammatory Bowel Disease. The American Journal of Gastroenterology. 111. S333–S333.
17.
Bellaguarda, Emanuelle, Kian Keyashian, Joel Pekow, et al.. (2015). Prevalence of Antibodies Against JC Virus in Patients With Refractory Crohn’s Disease and Effects of Natalizumab Therapy. Clinical Gastroenterology and Hepatology. 13(11). 1919–1925. 18 indexed citations
18.
Bellaguarda, Emanuelle & Eugene B. Chang. (2015). IBD and the Gut Microbiota—from Bench to Personalized Medicine. Current Gastroenterology Reports. 17(4). 15–15. 47 indexed citations
19.
Bellaguarda, Emanuelle, Joel Pekow, Russell D. Cohen, David T. Rubin, & Atsushi Sakuraba. (2014). Mo1183 Prevalence of Serum JC Virus Antibody in Refractory Crohn's Disease Patients. Gastroenterology. 146(5). S–580. 1 indexed citations
20.
Leal, Raquel Franco, Marc A. Ward, Maria de Lourdes Setsuko Ayrizono, et al.. (2013). Free peritoneal perforation in a patient with Crohn’s disease – Report of a case. International Journal of Surgery Case Reports. 4(3). 322–324. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J.‐F. Rahier Breakdown of academic impact, for papers by Klaus Theede Breakdown of academic impact, for papers by Katia El Jurdi Breakdown of academic impact, for papers by Jordi Gordillo Breakdown of academic impact, for papers by Colombel Jf Breakdown of academic impact, for papers by Victoria Rai Breakdown of academic impact, for papers by Aurada Cholapranee Breakdown of academic impact, for papers by Camilla Solberg Breakdown of academic impact, for papers by Petrease H Patton Breakdown of academic impact, for papers by Steven Jeuring
Rankless by CCL
2026